SCHEMBL30262145

CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	MC4R	P32245	1/20	0.59

▸	APLNR	P35414	2/20	0.56

▸	C5AR1	P21730	1/20	0.56

▸	NPY2R	P49146	7/20	0.56

▸	NPY4R	P50391	7/20	0.56

▸	NPY5R	Q15761	7/20	0.56

▸	NPY1R	P25929	5/20	0.56

▸	GLP1R	P43220	3/20	0.56

▸	GCGR	P47871	3/20	0.56

▸	KDM1A	O60341	1/20	0.54

▸	CALCR	P30988	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30712933	0.91	C5AR1 (0.62)	APLNRC5AR1NPY2RNPY4RNPY5R
SCHEMBL30073937	0.89	F2 (0.62)	MC4RAPLNRC5AR1NPY2RNPY4R
SCHEMBL31386983	0.89	C5AR1 (0.58)	MC4RC5AR1NPY2RNPY4RNPY5R
SCHEMBL30058340	0.88	F2 (0.63)	APLNRC5AR1NPY2RNPY4RNPY5R
SCHEMBL29525147	0.88	APLNR (0.63)	MC4RAPLNRC5AR1NPY2RNPY4R
SCHEMBL29416007	0.88	APLNR (0.58)	APLNRC5AR1NPY2RNPY4RNPY5R
SCHEMBL30646311	0.88	APLNR (0.58)	APLNRC5AR1NPY2RNPY4RNPY5R
SCHEMBL30432183	0.87	F2 (0.59)	APLNRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30358141	0.87	APLNR (0.63)	APLNRC5AR1KDM1ACALCR
SCHEMBL31174210	0.87	MC4R (0.60)	MC4RAPLNRC5AR1CALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230040544-A1	COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC)	SAREPTA THERAPEUTICS, INC.	2023-02-09	—	—	US	disclosed